Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-β-disease) a cause or an effect of increased apolipoprotein E levels? (Q40022085)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 1, 1976

Language	Label	Description	Also known as
English	Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-β-disease) a cause or an effect of increased apolipoprotein E levels?	scientific article published on November 1, 1976

Statements

scholarly article

1 reference

Europe PubMed Central

16 September 2017

Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels? (English)

1 reference

Europe PubMed Central

16 September 2017

Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-β-disease) a cause or an effect of increased apolipoprotein E levels? (English)

1 reference

10.1016/S0026-0495(76)80001-7

https://api.crossref.org/works/10.1016/S0026-0495(76)80001-7

26 December 2022

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0026-0495(76)80001-7

https://api.crossref.org/works/10.1016/S0026-0495(76)80001-7

26 December 2022

author name string

D. Ganesan

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185483

26 December 2022

H. B. Bass

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185483

26 December 2022

W. J. McConathy

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185483

26 December 2022

P. Alaupovic

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A185483

26 December 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=185483

26 December 2022

publication date

1 November 1976

1 reference

Europe PubMed Central

16 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0026049576800017?httpAccept=text/xml

1 reference

10.1016/S0026-0495(76)80001-7

https://api.crossref.org/works/10.1016/S0026-0495(76)80001-7

26 December 2022

https://api.elsevier.com/content/article/PII:S0026049576800017?httpAccept=text/plain

1 reference

10.1016/S0026-0495(76)80001-7

https://api.crossref.org/works/10.1016/S0026-0495(76)80001-7

26 December 2022

1 reference

Europe PubMed Central

16 September 2017

25

1 reference

Europe PubMed Central

16 September 2017

11

1 reference

Europe PubMed Central

16 September 2017

1189-1195

1 reference

Europe PubMed Central

16 September 2017

Purified postheparin plasma lipoprotein lipase in primary hyperlipoproteinemias

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E-III) in the very-low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Activation of highly purified lipoprotein lipase from bovine milk

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Isolation of C‐I and C‐II activated lipoprotein lipases and protamine insensitive triglyceride lipase by heparin‐sepharose affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Very low density lipoprotein subfractions in a subject with broad-β disease (type III hyperlipoproteinemia) and a subject with endogenous lipemia (type IV) chemical composition and electrophoretic mobility

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2876%2980001-7

7 January 2021

Identifiers

10.1016/S0026-0495(76)80001-7

1 reference

Europe PubMed Central

16 September 2017

1 reference

Europe PubMed Central

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40022085&oldid=1795977381"